RENAL PERIVASCULAR EPITHELIOID CELL TUMOUR

This adverse event was reported 26 times

These drugs are most commonly taken by patients reporting RENAL PERIVASCULAR EPITHELIOID CELL TUMOUR:

# Drug Count
0 EVEROLIMUS 6
1 ASFOTASE ALFA 4
2 EVEROLIMUS TABLETS 4
3 SECUKINUMAB 3
4 VEDOLIZUMAB 3
5 ASPIRIN 2
6 ASPIRIN 325 MG 2
7 ASPIRIN 81 MG 2
8 AZATHIOPRINE 2
9 CABERGOLINE 2
See all common drugs associated with RENAL PERIVASCULAR EPITHELIOID CELL TUMOUR

RENAL PERIVASCULAR EPITHELIOID CELL TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DAPRODUSTAT 1 0.0005
1 LEBRIKIZUMAB-LBKZ 1 0.0004
2 CABERGOLINE 2 0.0004
3 ASFOTASE ALFA 4 0.0004
4 EVEROLIMUS TABLETS 4 0.0002
5 PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF 1 0.0002
6 FENFLURAMINE 1 0.0002
7 NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE 1 0.0002
8 IVABRADINE 1 0.0001
9 EVEROLIMUS 6 0.0001
See all drugs enriched for association with RENAL PERIVASCULAR EPITHELIOID CELL TUMOUR